IATL inhibits breast cancer cell adhesion, migration, and invasion via the p38 MAPK/NF-κB signaling pathway, and the activity and expression of MMP-2 and MMP-9 are downregulated by IATL in a dose-dependent manner [36]. This evidence concerns the gene NFKB1 and breast carcinoma.